Secondly, owing to limited access to clinical tissue samples, all analyses focused on the expression of TRIB3 in ccRCC tissue samples, and the correlations between the levels of TRIB3 and patient outcomes were assessed based on data from the TCGA database. This evidence concerns the gene TRIB3 and nonpapillary renal cell carcinoma.